Gammanorm Solution for Injection 165mg/ml (48ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (48ml vial)

octapharma (ip) limited - human normal immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

Gammanorm Solution for Injection 165mg/ml (10ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (10ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

Gammanorm Solution for Injection 165mg/ml (12ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (12ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

Gammanorm Solution for Injection 165mg/ml (20ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (20ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

Gammanorm Solution for Injection 165mg/ml (24ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (24ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

Gammanorm Solution for Injection 165mg/ml (48ml vial) Malta - engelsk - Malta Medicines Authority

gammanorm solution for injection 165mg/ml (48ml vial)

octapharma (ip) sprl alle de la recherche 65, 1070 (anderlecht), belgium - human normal, immunoglobulin - solution for injection - human normal immunoglobulin 165 mg/ml - immune sera and immunoglobulins

HIZENTRA Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 20 mL pre-filled syringe Australien - engelsk - Department of Health (Therapeutic Goods Administration)

hizentra human normal immunoglobulin 20% solution for subcutaneous injection 20 ml pre-filled syringe

csl behring australia pty ltd - normal immunoglobulin, quantity: 4 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 20 mL vial Australien - engelsk - Department of Health (Therapeutic Goods Administration)

hizentra au human normal immunoglobulin 20% solution for subcutaneous injection 20 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 4 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 10 mL vial Australien - engelsk - Department of Health (Therapeutic Goods Administration)

hizentra au human normal immunoglobulin 20% solution for subcutaneous injection 10 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 2 g - injection, solution - excipient ingredients: polysorbate 80; proline; water for injections - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.

HIZENTRA AU Human Normal Immunoglobulin 20% Solution for Subcutaneous Injection 5 mL vial Australien - engelsk - Department of Health (Therapeutic Goods Administration)

hizentra au human normal immunoglobulin 20% solution for subcutaneous injection 5 ml vial

csl behring australia pty ltd - normal immunoglobulin, quantity: 1 g - injection, solution - excipient ingredients: water for injections; proline; polysorbate 80 - replacement therapy in adults and children in: - primary immunodeficiency disease (pid) and - symptomatic hypogammaglobulinaemia secondary to underlying disease or treatment. immunomodulatory therapy in: - chronic inflammatory demyelinating polyneuropathy (cidp) as maintenance therapy after stabilisation with ivig.